Lin; Chen-Yong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lin; Chen-Yong.The latest application filed is for "targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties".

Company Profile

3.9.14

Lin; Chen-Yong - Falls Church VA
Lin; Chen-Yong - Hsin-Chu TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Anti-matriptase Antibodies By In Vivo Cleavable Linking Moieties App 20210299270 - Lin; Siang-Yo ; et al.	2021-09-30
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20210177985 - Lin; Siang-Yo ; et al.	2021-06-17
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20190358340 - Lin; Siang-Yo ; et al.	2019-11-28
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies Grant 10,376,597 - Lin , et al. A	2019-08-13
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Anti-matriptase Antibodies By In Vivo Cleavable Linking Moietie App 20190151464 - Lin; Siang-Yo ; et al.	2019-05-23
Markers for abnormal cells Grant 10,175,238 - Lin , et al. J	2019-01-08
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20180177889 - Lin; Siang-Yo ; et al.	2018-06-28
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies Grant 9,849,192 - Lin , et al. December 26, 2	2017-12-26
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjugated to matriptase antibodies Grant 9,682,094 - Lin , et al. June 20, 2	2017-06-20
Specific delivery of toxins conjugated with antibodies to activate matripase Grant 9,549,993 - Lin , et al. January 24, 2	2017-01-24
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20160263244 - Lin; Siang-Yo ; et al.	2016-09-15
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20160015728 - Lin; Siang-Yo ; et al.	2016-01-21
Markers for Abnormal Cells App 20150338409 - Lin; Chen-Yong ; et al.	2015-11-26
Specific Delivery of Toxins Conjugated with Antiobodies to Activate Matripase App 20150250895 - Lin; Siang-Yo ; et al.	2015-09-10
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20120294800 - Lin; Siang-Yo ; et al.	2012-11-22
Matriptase, a serine protease and its applications Grant 7,960,163 - Dickson , et al. June 14, 2	2011-06-14
Matriptase, A Serine Protease And Its Applications App 20080248566 - Dickson; Robert B. ; et al.	2008-10-09
Matriptase, a serine protease and its applications Grant 7,355,015 - Dickson , et al. April 8, 2	2008-04-08
Single polysilicon process for DRAM Grant 7,037,776 - Huang , et al. May 2, 2	2006-05-02
Single polysilicon process for dram App 20040121533 - Huang, Jenn-Ming ; et al.	2004-06-24
Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions Grant 6,677,377 - Lin , et al. January 13, 2	2004-01-13
Activation of matriptase and diagnostic and therapeutic methods based thereon App 20030170245 - Dickson, Robert B. ; et al.	2003-09-11
Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions App 20030092752 - Lin, Chen-Yong ; et al.	2003-05-15

Company Registrations

NCAGE Code	50KK6	LIN, CHEN-YONG
CAGE Code	50KK6	LIN, CHEN-YONG

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.